Cargando…
Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740946/ https://www.ncbi.nlm.nih.gov/pubmed/34362818 http://dx.doi.org/10.2337/dc21-1192 |
_version_ | 1784629402925006848 |
---|---|
author | Cohen, Ricardo V. Petry, Tarissa Beatrice Zanata Miras, Alexander Dimitri Aboud, Cristina Mamédio Johnson, Brett dos Santos, Tiago Mendonça le Roux, Carel W. |
author_facet | Cohen, Ricardo V. Petry, Tarissa Beatrice Zanata Miras, Alexander Dimitri Aboud, Cristina Mamédio Johnson, Brett dos Santos, Tiago Mendonça le Roux, Carel W. |
author_sort | Cohen, Ricardo V. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8740946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-87409462022-01-10 Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial Cohen, Ricardo V. Petry, Tarissa Beatrice Zanata Miras, Alexander Dimitri Aboud, Cristina Mamédio Johnson, Brett dos Santos, Tiago Mendonça le Roux, Carel W. Diabetes Care e-Letters – Observations American Diabetes Association 2021-10 2021-08-06 /pmc/articles/PMC8740946/ /pubmed/34362818 http://dx.doi.org/10.2337/dc21-1192 Text en © 2021 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
spellingShingle | e-Letters – Observations Cohen, Ricardo V. Petry, Tarissa Beatrice Zanata Miras, Alexander Dimitri Aboud, Cristina Mamédio Johnson, Brett dos Santos, Tiago Mendonça le Roux, Carel W. Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial |
title | Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial |
title_full | Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial |
title_fullStr | Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial |
title_full_unstemmed | Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial |
title_short | Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial |
title_sort | renoprotective effects of the combination of empagliflozin and liraglutide compared with roux-en-y gastric bypass in early-stage diabetic kidney disease: a post hoc analysis of the microvascular outcomes after metabolic surgery (moms) randomized controlled clinical trial |
topic | e-Letters – Observations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740946/ https://www.ncbi.nlm.nih.gov/pubmed/34362818 http://dx.doi.org/10.2337/dc21-1192 |
work_keys_str_mv | AT cohenricardov renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial AT petrytarissabeatricezanata renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial AT mirasalexanderdimitri renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial AT aboudcristinamamedio renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial AT johnsonbrett renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial AT dossantostiagomendonca renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial AT lerouxcarelw renoprotectiveeffectsofthecombinationofempagliflozinandliraglutidecomparedwithrouxenygastricbypassinearlystagediabetickidneydiseaseaposthocanalysisofthemicrovascularoutcomesaftermetabolicsurgerymomsrandomizedcontrolledclinicaltrial |